Witty Technology Co., Ltd. Announces Correction to Important Accounting Items in 2025 Individual Financial Report

Witty Technology Co., Ltd. announced on April 9, 2026, a correction to misstated amounts for "Depreciation" and "Other" under "Research and Development Expenses" in the detailed statement of important accounting items (Statement 13: Operating Expenses Statement) of its 2025 individual financial report. This correction has no impact on the total operating expenses, net profit for the period, or shareholders' equity in the originally announced comprehensive income statement. The company plans to issue a material information announcement on the Market Observation Post System and re-announce the report.
financialNQ 100/100出典:PR Times

📋 Article Processing Timeline

  • 📰 Published: April 9, 2026 at 09:00
  • 🔍 Collected: April 10, 2026 at 08:00 (23h 0m after Published)
  • 🤖 AI Analyzed: April 15, 2026 at 12:00 (124h 0m after Collected)
1.Date of occurrence of the event:2026/04/09
2.Company name:Witty Technology Co., Ltd.
3.Relationship with the company (please enter "the company" or "subsidiary"):The company
4.Mutually held shares percentage:Not applicable
5.Reason for the occurrence:In accordance with the instructions of the competent authority, to correct the misstated amounts for "Depreciation," "Other," and "Total" under "Research and Development Expenses" in the detailed statement of important accounting items (Statement 13: Operating Expenses Statement) of the company's 2025 individual financial report.
This case is merely a simple correction of misstatements in the supplementary detailed statements of the financial report and has no impact on the total operating expenses, net profit for the period, or shareholders' equity in the originally announced comprehensive income statement.
6.Corrected information item/report name:2025 Individual Financial Report, Detailed Statement of Important Accounting Items (Statement 13: Operating Expenses Statement)
7.Amount/content/page before correction:
2025 Individual Financial Report
Detailed Statement of Important Accounting Items Statement 13: Operating Expenses Statement / P.93
Item Selling Expenses General & Administrative Expenses Research and Development Expenses
Salaries $26,765 $59,446 $128,856
Import/Export Fees 4,857 6 4
Travel Expenses 3,630 1,980 4,764
Insurance Expenses 2,689 7,707 11,251
Depreciation 1,420 14,999 12
Research Expenses - - 46,441
Other (Note) 9,201 45,705 20
$48,562 $129,843 $191,348
8.Amount/content/page after correction:
2025 Individual Financial Report
Detailed Statement of Important Accounting Items Statement 13: Operating Expenses Statement / P.93
Item Selling Expenses General & Administrative Expenses Research and Development Expenses
Salaries $26,765 $59,446 $128,856
Import/Export Fees 4,857 6 4
Travel Expenses 3,630 1,980 4,764
Insurance Expenses 2,689 7,707 11,251
Depreciation 1,420 14,999 11,648
Research Expenses - - 46,441
Other (Note) 9,201 45,705 20,033
$48,562 $129,843 $222,997
9.Countermeasures:A material information announcement will be issued on the Market Observation Post System and re-announced.
10.Other matters that need to be specified:None.

FAQ

What correction did Witty Technology Co., Ltd. announce on April 9, 2026?

Witty Technology corrected misstated amounts for 'Depreciation' and 'Other' in R&D expenses in its 2025 financial report.

Which financial report year was affected by Witty Technology's correction announcement?

The 2025 individual financial report of Witty Technology Co., Ltd. contained the corrected accounting items.

Did the correction impact the total operating expenses in Witty Technology's 2025 report?

No, the correction did not affect the total operating expenses in Witty Technology's 2025 financial report.

Where will Witty Technology Co., Ltd. publish its material information announcement?

Witty Technology will publish the announcement on the Market Observation Post System.

What specific line items in Statement 13 were corrected by Witty Technology in 2025?

The 'Depreciation' and 'Other' categories under Research and Development Expenses in Statement 13 were corrected.